KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash from Investing Activities (2016 - 2026)

Elevance Health has reported Cash from Investing Activities over the past 17 years, most recently at -$1.6 billion for Q1 2026.

  • Quarterly Cash from Investing Activities fell 1694.17% to -$1.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$3.1 billion through Mar 2026, down 12.16% year-over-year, with the annual reading at -$1.3 billion for FY2025, 73.99% up from the prior year.
  • Cash from Investing Activities was -$1.6 billion for Q1 2026 at Elevance Health, down from $464.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $464.0 million in Q4 2025 and troughed at -$3.2 billion in Q1 2023.
  • The 5-year median for Cash from Investing Activities is -$1.0 billion (2023), against an average of -$1.1 billion.
  • Biggest five-year swings in Cash from Investing Activities: surged 129.92% in 2022 and later tumbled 1694.17% in 2026.
  • Tracing ELV's Cash from Investing Activities over 5 years: stood at $289.0 million in 2022, then plummeted by 456.06% to -$1.0 billion in 2023, then tumbled by 59.18% to -$1.6 billion in 2024, then soared by 128.33% to $464.0 million in 2025, then plummeted by 453.88% to -$1.6 billion in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$1.6 billion, $464.0 million, and -$1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.